These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1625089)

  • 1. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.
    Griffin TC; Buchanan GR
    J Pediatr; 1992 Jul; 121(1):28-33. PubMed ID: 1625089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
    Bash RO; Katz JA; Cash JV; Buchanan GR
    Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia.
    Aquino VM; Buchanan GR; Tkaczewski I; Mustafa MM
    Med Pediatr Oncol; 1997 Mar; 28(3):191-5. PubMed ID: 9024515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.
    Mullen CA; Buchanan GR
    J Clin Oncol; 1990 Dec; 8(12):1998-2004. PubMed ID: 2230891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to treatment of the febrile cancer patient with low-risk neutropenia.
    Buchanan GR
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):919-35. PubMed ID: 8226566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition.
    Jones GR; Konsler GK; Dunaway RP; Gold SH; Cooper HA; Wells RJ
    J Pediatr; 1994 May; 124(5 Pt 1):703-8. PubMed ID: 8176555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
    Hodgson-Viden H; Grundy PE; Robinson JL
    BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fever and neutropenia in children with malignant disease.
    Roguin A; Kasis I; Ben-Arush MW; Sharon R; Berant M
    Pediatr Hematol Oncol; 1996; 13(6):503-10. PubMed ID: 8940733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.
    Campbell ME; Friedman DL; Dulek DE; Zhao Z; Huang Y; Esbenshade AJ
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early discharge of low-risk febrile neutropenic children and adolescents with cancer.
    Aquino VM; Tkaczewski I; Buchanan GR
    Clin Infect Dis; 1997 Jul; 25(1):74-8. PubMed ID: 9243037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever.
    Vettenranta K; Hovi L; Mäkipernaa A; Jalanko H; Saarinen-Pihkala UM
    Acta Paediatr; 2002; 91(8):915-9. PubMed ID: 12222715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia.
    Klaassen RJ; Allen U; Doyle JJ
    J Pediatr Hematol Oncol; 2000; 22(5):405-11. PubMed ID: 11037850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.
    Lehrnbecher T; Stanescu A; Kühl J
    Infection; 2002 Jan; 30(1):17-21. PubMed ID: 11876510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. A preliminary prospective trial.
    Cohen KJ; Leamer K; Odom L; Greffe B; Stork L
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):325-30. PubMed ID: 7583388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia.
    Kobayashi R; Matsushima S; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1056-1060. PubMed ID: 32800573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics.
    Lau RC; Doyle JJ; Freedman MH; King SM; Richardson SE
    Pediatr Hematol Oncol; 1994; 11(4):417-21. PubMed ID: 7947014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological changes and predictors of bone marrow recovery in patients with neutropenic episodes in acute lymphoblastic leukemia.
    Bhatnagar S; Chandra J; Narayan S
    J Trop Pediatr; 2002 Aug; 48(4):200-3. PubMed ID: 12200979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
    Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
    Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating Absolute Phagocyte Count With Absolute Neutrophil Count as a Measure for Safe Discharge for Pediatric Oncology Febrile Neutropenia: A Pilot Study.
    Picca A; Wahlquist AE; Hudspeth M
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1000-e1002. PubMed ID: 33065712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.